0001104659-20-128061.txt : 20201120 0001104659-20-128061.hdr.sgml : 20201120 20201120173630 ACCESSION NUMBER: 0001104659-20-128061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201120 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOMTAZEE JAMES C CENTRAL INDEX KEY: 0001209181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39597 FILM NUMBER: 201333608 MAIL ADDRESS: STREET 1: 2755 CAMPUS DRIVE, SUITE 240 CITY: SAN MATEO STATE: CA ZIP: 94403-2538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Montes Archimedes Acquisition Corp CENTRAL INDEX KEY: 0001819263 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 212-446-4600 MAIL ADDRESS: STREET 1: 724 OAK GROVE, SUITE 130 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 a4.xml 4 X0306 4 2020-11-20 0 0001819263 Montes Archimedes Acquisition Corp MAAC 0001209181 MOMTAZEE JAMES C 724 OAK GROVE, SUITE 130 MENLO PARK CA 94025 1 1 1 0 Chief Executive Officer Class B common stock 2020-11-20 4 J 0 1232044 D Class A common stock 1232044 10167956 I By Patient Square Capital LLC This Form 4 reflects the automatic surrender to the issuer of 1,285,637 of the issuer's shares of Class B common stock, par value $0.0001 per share, for no consideration by the Patient Square Capital LLC (the "Sponsor") pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriter of the issuer's initial public offering to purchase additional units. As described in the issuer's registration statement on Form S-1 (File No. 333-248802) under the heading "Description of Securities-Founder Shares", the shares of Class B common stock, par value $0.0001, will automatically convert into shares of Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial partnering transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. The securities reported herein are held by the Sponsor. The reporting person controls the Sponsor, and as such has voting and investment discretion with respect to the securities held by the the Sponsor and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. /s/ James C. Momtazee 2020-11-20